文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

卵巢癌中的健康差异:卵巢癌证据审查会议报告。

Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference.

机构信息

Departments of Obstetrics and Gynecology, New York University Langone School of Medicine, New York, New York, Virginia Commonwealth University School of Medicine, Richmond, Virginia, the Medical College of Wisconsin, Milwaukee, Wisconsin, Creighton University School of Medicine, Phoenix, Arizona, the University of California, Davis, Davis, California, the University of Iowa Hospitals and Clinics, Ames, Iowa, and Stony Brook University Hospital, New York, New York; and the American College of Obstetricians and Gynecologists, Washington, DC.

出版信息

Obstet Gynecol. 2023 Jul 1;142(1):196-210. doi: 10.1097/AOG.0000000000005210. Epub 2023 Jun 7.


DOI:10.1097/AOG.0000000000005210
PMID:37348095
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10278570/
Abstract

Health disparity, defined by the Centers for Disease Control and Prevention (CDC) as "preventable differences in the burden of disease, injury, violence, or opportunities to achieve optimal health that are experienced by socially disadvantaged populations," is seen across multiple diseases. We conducted an evidence review of health disparities and inequities and their mitigation strategies related to ovarian cancer as part of a CDC-sponsored project to develop educational materials for clinicians on the prevention and early diagnosis of gynecologic cancers. Our review found profound disparities in outcomes such as survival, treatment, and stage at diagnosis by factors such as race and ethnicity, insurance, socioeconomic status, and geographic location. We found little direct evidence on mitigation strategies. Studies support equivalent response to equivalent treatment between groups, suggesting that adherence to National Comprehensive Cancer Network guidelines can at least partially mitigate some of the differences.

摘要

健康差异是指由疾病控制和预防中心(CDC)定义的“社会弱势群体在疾病、伤害、暴力或实现最佳健康机会方面所承受的可预防的负担差异”,在多种疾病中都存在。我们对卵巢癌相关的健康差异和不公平及其缓解策略进行了证据回顾,这是 CDC 资助的一个项目的一部分,该项目旨在为临床医生开发关于妇科癌症预防和早期诊断的教育材料。我们的审查发现,种族和民族、保险、社会经济地位和地理位置等因素导致生存、治疗和诊断阶段等结果存在明显差异。我们几乎没有关于缓解策略的直接证据。研究支持在不同群体之间对同等治疗的等效反应,这表明遵守国家综合癌症网络指南至少可以部分缓解其中一些差异。

相似文献

[1]
Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference.

Obstet Gynecol. 2023-7-1

[2]
A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review.

Gynecol Oncol. 2018-4

[3]
American Cancer Society's report on the status of cancer disparities in the United States, 2023.

CA Cancer J Clin. 2024

[4]
Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.

Obstet Gynecol. 2015-4

[5]
Role of neighborhood context in ovarian cancer survival disparities: current research and future directions.

Am J Obstet Gynecol. 2023-10

[6]
Looking at cancer health disparities in gynecologic oncology in 2020.

Curr Opin Obstet Gynecol. 2021-8-1

[7]
Disparities in Genetic Management of Breast and Ovarian Cancer Patients.

Obstet Gynecol Surv. 2024-11

[8]
Adherence to treatment guidelines as a major determinant of survival disparities between black and white patients with ovarian cancer.

Gynecol Oncol. 2021-1

[9]
Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.

J Natl Cancer Inst. 2013-3-28

[10]
Disparities in Respiratory Syncytial Virus Risk Factors, Diagnosis, and Outcomes in Adults by Race, Ethnicity, and Other Social Determinants of Health in the United States.

Expert Rev Pharmacoecon Outcomes Res. 2025-4

引用本文的文献

[1]
Association of social vulnerability with access to treatment in ovarian cancer patients.

Gynecol Oncol Rep. 2025-7-20

[2]
Tumoroid model recreates clinically relevant phenotypes of high grade serous ovarian cancer (HGSC) cells, carcinoma associated fibroblasts, and macrophages.

Res Sq. 2025-6-19

[3]
Gynecological Cancers Among American Indian and Alaska Native Women Living in the Upper Midwest, 1995-2019.

Womens Health Rep (New Rochelle). 2025-2-25

[4]
A Comparison of Neighborhood Socioeconomic Deprivation Measures and the Association with Survival among Black and White Women with Endometrial Cancer.

Cancer Epidemiol Biomarkers Prev. 2025-6-3

[5]
All-cause mortality and neighborhood social vulnerability among women with ovarian cancer.

Gynecol Oncol. 2025-4

[6]
Worldwide patterns and trends in ovarian cancer incidence by histological subtype: a population-based analysis from 1988 to 2017.

EClinicalMedicine. 2024-12-6

[7]
Association of neighborhood social vulnerability with ovarian cancer survival.

Gynecol Oncol. 2025-1

[8]
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London.

Cancers (Basel). 2024-10-24

[9]
Exploring social determinants of health on chemotherapy-induced peripheral neuropathy severity in ovarian cancer: An integrative review.

Gynecol Oncol Rep. 2024-9-21

[10]
Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021.

EClinicalMedicine. 2024-7-2

本文引用的文献

[1]
Executive Summary of the Ovarian Cancer Evidence Review Conference.

Obstet Gynecol. 2023-7-1

[2]
Executive Summary of the Uterine Cancer Evidence Review Conference.

Obstet Gynecol. 2022-4-1

[3]
Health Disparities in Uterine Cancer: Report From the Uterine Cancer Evidence Review Conference.

Obstet Gynecol. 2022-4-1

[4]
Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients.

Am J Clin Oncol. 2021-10-1

[5]
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.

Gynecol Oncol. 2021-8

[6]
Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance.

Gynecol Oncol. 2021-7

[7]
Rural disparities in surgical care from gynecologic oncologists among Midwestern ovarian cancer patients.

Gynecol Oncol. 2021-2

[8]
Race, Socioeconomic Status, and Health-Care Access Disparities in Ovarian Cancer Treatment and Mortality: Systematic Review and Meta-Analysis.

JNCI Cancer Spectr. 2019-10-9

[9]
Clear differences in ovarian cancer incidence and trends by ethnicity among Asian Americans.

Cancer Epidemiol. 2019-6-26

[10]
Identifying disparities in germline and somatic testing for ovarian cancer.

Gynecol Oncol. 2019-3-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索